Two Sigma Advisers’s Tenet Healthcare THC Stock Holding History

Two Sigma Advisers’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-7,000	Closed	-$323K	–	2381
2013 Q2	$323K	Buy	+7,000	New	+$313K	﹤0.01%	1664

Other funds holding THC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's THC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Tenet Healthcare (THC) in Q1 2026, closing a stake of 70,000 shares — an estimated $13.9M sold.

Two Sigma Advisers first reported a position in THC in Q2 2013 and held it in 33 quarters. The position peaked at $18.6M in Q2 2018. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

Two Sigma Advisers reported no remaining Tenet Healthcare position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 70,000 Tenet Healthcare shares in Q1 2026, an estimated $13.9M.
Two Sigma Advisers first reported a position in Tenet Healthcare in Q2 2013 and held it in 33 quarters.
Two Sigma Advisers's Tenet Healthcare position peaked at $18.6M in Q2 2018.
690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.